Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.

Saved in:
Bibliographic Details
Title: Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.
Authors: Dudukina E; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark. e.dudukina@clin.au.dk., Szépligeti SK; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark., Karlsson P; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden., Asomaning K; Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA., Daltveit AK; Department of Global Public Health and Primary Care, University of Bergen, Årstadveien 17, 5009, Bergen, Norway.; Department of Health Registries, Norwegian Institute of Public Health, Bergen, Norway., Hakkarainen K; Global Database Studies, Real World Solutions, IQVIA, Pyramidvägen 7, 169 56, Solna, Sweden., Hoti F; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland., Kieler H; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden., Lunde A; Department of Global Public Health and Primary Care, University of Bergen, Årstadveien 17, 5009, Bergen, Norway., Odsbu I; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Mental Disorders, Norwegian Institute of Public Health, Sandakerveien 24c, Bygg B, 0473, Oslo, Norway., Rantanen M; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland., Reutfors J; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden., Saarelainen L; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland., Ehrenstein V; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark., Toft G; Steno Diabetes Center Aarhus, Palle Juul-Jensens Boulevard 11, 8200, Aarhus N, Denmark.
Source: Drug safety [Drug Saf] 2023 Jul; Vol. 46 (7), pp. 661-675. Date of Electronic Publication: 2023 Apr 26.
Publication Type: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37099261
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dudukina+E%22">Dudukina E</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark. e.dudukina@clin.au.dk.<br /><searchLink fieldCode="AU" term="%22Szépligeti+SK%22">Szépligeti SK</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.<br /><searchLink fieldCode="AU" term="%22Karlsson+P%22">Karlsson P</searchLink>; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Asomaning+K%22">Asomaning K</searchLink>; Pfizer Inc., 500 Arcola Road, Collegeville, PA, 19426, USA.<br /><searchLink fieldCode="AU" term="%22Daltveit+AK%22">Daltveit AK</searchLink>; Department of Global Public Health and Primary Care, University of Bergen, Årstadveien 17, 5009, Bergen, Norway.; Department of Health Registries, Norwegian Institute of Public Health, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Hakkarainen+K%22">Hakkarainen K</searchLink>; Global Database Studies, Real World Solutions, IQVIA, Pyramidvägen 7, 169 56, Solna, Sweden.<br /><searchLink fieldCode="AU" term="%22Hoti+F%22">Hoti F</searchLink>; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland.<br /><searchLink fieldCode="AU" term="%22Kieler+H%22">Kieler H</searchLink>; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lunde+A%22">Lunde A</searchLink>; Department of Global Public Health and Primary Care, University of Bergen, Årstadveien 17, 5009, Bergen, Norway.<br /><searchLink fieldCode="AU" term="%22Odsbu+I%22">Odsbu I</searchLink>; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.; Department of Mental Disorders, Norwegian Institute of Public Health, Sandakerveien 24c, Bygg B, 0473, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Rantanen+M%22">Rantanen M</searchLink>; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland.<br /><searchLink fieldCode="AU" term="%22Reutfors+J%22">Reutfors J</searchLink>; Centre for Pharmacoepidemiology, Karolinska Institutet, Karolinska University Hospital, 171 76, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Saarelainen+L%22">Saarelainen L</searchLink>; Global Database Studies, Real World Solutions, IQVIA, Spektri, Duo Building, Metsänneidonkuja 6, 02130, Espoo, Finland.<br /><searchLink fieldCode="AU" term="%22Ehrenstein+V%22">Ehrenstein V</searchLink>; Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark.<br /><searchLink fieldCode="AU" term="%22Toft+G%22">Toft G</searchLink>; Steno Diabetes Center Aarhus, Palle Juul-Jensens Boulevard 11, 8200, Aarhus N, Denmark.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2023 Jul; Vol. 46 (7), pp. 661-675. <i>Date of Electronic Publication: </i>2023 Apr 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Meta-Analysis; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37099261
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40264-023-01307-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 661
    Titles:
      – TitleFull: Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dudukina E
      – PersonEntity:
          Name:
            NameFull: Szépligeti SK
      – PersonEntity:
          Name:
            NameFull: Karlsson P
      – PersonEntity:
          Name:
            NameFull: Asomaning K
      – PersonEntity:
          Name:
            NameFull: Daltveit AK
      – PersonEntity:
          Name:
            NameFull: Hakkarainen K
      – PersonEntity:
          Name:
            NameFull: Hoti F
      – PersonEntity:
          Name:
            NameFull: Kieler H
      – PersonEntity:
          Name:
            NameFull: Lunde A
      – PersonEntity:
          Name:
            NameFull: Odsbu I
      – PersonEntity:
          Name:
            NameFull: Rantanen M
      – PersonEntity:
          Name:
            NameFull: Reutfors J
      – PersonEntity:
          Name:
            NameFull: Saarelainen L
      – PersonEntity:
          Name:
            NameFull: Ehrenstein V
      – PersonEntity:
          Name:
            NameFull: Toft G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2023 Jul
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1942
          Numbering:
            – Type: volume
              Value: 46
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Drug safety
              Type: main
ResultId 1